1. Coventry, B. J. et al. CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? J Transl Med 7, 102,
https://doi.org/10.1186/1479-5876-7-102
(2002).
2. Rudnicka, A. R., Rumley, A., Lowe, G. D. O. & Strachan, D. P. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circ. 2007(115), 996–1003 (2002).
3. Pepys, M. B. The acute phase response and C-reactive protein. Oxf. Univ. Press. second edition, 1527–1533 (1995).
4. Szkandera, J. R., Stotz, M. & Absenger, G. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer 110(1), 183–188 (2014).
5. Fang, S., Wang, Y. & Sui, D. C-reactive protein as a marker of melanoma progression. J Clin Oncol. 33(12), 1389–96 (2015).